Wiley develops AI guidelines in response to demand from researchers
Find out more about the guidelines aiming to embrace use of AI, ethically.
Why aren’t more journals publishing plain language summaries?
A recent survey sheds light on publisher perspectives on plain language summaries and the barriers to their wider adoption.
Are conflicts of interest reported transparently in healthcare guidelines?
Discover the RIGHT-COI&F checklist, developed to improve conflict of interest and funding reporting in healthcare guidelines.
Publisher policies on AI use: is it time for change?
Find out how publisher AI policies need to evolve in the face of fast-changing technology.
Overcoming bias in ‘overviews of reviews’: a spotlight on appraisal tools
Planning to write an overview of systematic reviews? Uncover essential guidance on the effective use of tools to assess and minimise bias.
ICMJE recommendations update 2024: what’s new and what’s next?
All you need to know about the latest updates to the ICMJE recommendations.
SPIRIT-Outcomes 2022 Extension: guidelines for transparent inclusion of clinical trial outcomes in trial protocols
How to improve outcome reporting in clinical trial protocols: read more about the SPIRIT-Outcomes 2022 Extension.
CONSORT-Outcomes 2022 Extension: guidelines for complete reporting of clinical trial outcomes
The 17 items to include when reporting clinical trial outcomes. Read about the CONSORT-Outcomes 2022 Extension checklist for outcomes of all randomised clinical trials.
To tweet or not to tweet: social media guidance to help pharmaceutical companies adhere to the ABPI Code of Practice
Read about new guidance from the PMCPA that aims to ensure the social media activities of pharmaceutical companies stay within the law.
ICMJE recommendations update: what you need to know
Find out what’s new in the latest 2022 update to the ICMJE recommendations.
[VIDEO] Introducing GPP 2022
Find out what’s covered in the 2022 update to the Good Publication Practice guidelines.
CHEERS 2022 statement: reporting guidance for health economic evaluations gets a makeover
Read about the new 28-item checklist developed to aid decision-making in health economic evaluations.
What can be done to increase the transparency of real world studies?
Read about recent roundtable recommendations for improving the transparency of real world evidence dissemination.
What counts as a ‘substantial contribution’ to industry-sponsored research?
Recommendations from the ISMPP Authorship Task Force aim to clarify ICMJE guidelines on authorship selection criteria.
Is open research driving inequity in science?
Dr Tony Ross-Hellauer (ON-MERRITT) discusses how the move toward open research may exacerbate inequity and suggests strategies to prevent it.
How to assess the credibility of clinical trial findings?
Read about Cochrane reviewers’ approaches to detecting and tackling potential fraud in clinical trial publications.